Efficient and Robust Highly Branched Poly(β-amino ester)/Minicircle COL7A1 Polymeric Nanoparticles for Gene Delivery to Recessive Dystrophic Epidermolysis Bullosa Keratinocytes

ACS Applied Materials & Interfaces
Ming ZengWenxin Wang

Abstract

Recessive dystrophic epidermolysis bullosa (RDEB) is a severe congenital skin fragility disease caused by COL7A1 mutations that result in type VII collagen (C7) deficiency. Herein, we report a synergistic polyplex system that can efficiently restore C7 expression in RDEB keratinocytes. A highly branched multifunctional poly(β-amino ester) (HPAE), termed as HC32-122, was optimized systematically as the high-performance gene delivery vector for keratinocytes, achieving much higher transfection capability than polyethylenimine, SuperFect, and Lipofectamine 2000 without inducing obvious cytotoxicity. Concurrently, a 12 kb length minicircle DNA encoding ∼9 kb full-length COL7A1 (MCC7) devoid of bacterial sequence was biosynthesized as the therapeutic gene. Combining the highly potent polymer and the miniaturized gene structure, HC32-122/MCC7 polyplexes achieve 96.4% cellular uptake efficiency, 4019-fold COL7A1 mRNA enhancement, and robust recombinant C7 expression. Structure-property investigations reveal that HC32-122 can effectively condense MCC7 to form small, uniform, compact, and positively charged spherical nanoparticles with high DNA release flexibility. Moreover, formulation study shows that sucrose is conductive to lyophili...Continue Reading

References

May 2, 2003·Journal of the American Chemical Society·Akin AkincRobert Langer
Aug 30, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zhi-Ying ChenMark A Kay
Feb 25, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Daniel G AndersonRobert Langer
Jul 30, 2005·Nature Reviews. Drug Discovery·Daniel W PackPatrick S Stayton
Mar 21, 2006·Human Gene Therapy·Christopher BaumBoris Fehse
Jul 13, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hongtao LvJie Yan
Jul 4, 2007·Nature Reviews. Genetics·Reinhard WaehlerDavid T Curiel
Sep 9, 2008·British Journal of Pharmacology·D BouardF-L Cosset
Feb 3, 2009·Journal of Immunological Methods·Stefanos TheoharisAndrew J T George
Jul 2, 2009·Methods in Molecular Biology·Peter MayrhoferWolfgang Jechlinger
Dec 1, 2009·Dermatologic Clinics·Leena Bruckner-Tuderman
Aug 20, 2010·The Journal of Investigative Dermatology·Eva M MurauerJohann W Bauer
Sep 8, 2010·The New England Journal of Medicine·John E WagnerJakub Tolar
Nov 18, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mark J OsbornBruce R Blazar
Apr 3, 2012·Molecular Biotechnology·Dennis KobeltWolfgang Walther
Jul 9, 2013·Trends in Biotechnology·Pedro H Oliveira, Juergen Mairhofer
Jul 16, 2014·Nature Reviews. Genetics·Hao YinDaniel G Anderson
Dec 30, 2014·Expert Opinion on Biological Therapy·Vítor GasparFani Sousa
Feb 3, 2015·ACS Nano·Antonella MangravitiJordan J Green
Mar 5, 2015·Journal of Clinical and Diagnostic Research : JCDR·Murali Ramamoorth, Aparna Narvekar
Apr 22, 2015·Chemical Communications : Chem Comm·Jian-Yuan HuangWenxin Wang
Apr 24, 2015·The Journal of Investigative Dermatology·Gabriela PetrofJohn A McGrath
Jun 13, 2015·The Journal of Investigative Dermatology·David T Woodley, Mei Chen
Jun 16, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·Christopher PerdoniJakub Tolar
Aug 13, 2015·Biomacromolecules·Lara CutlarWenxin Wang
Dec 22, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marianna FoldvariAmirreza Rafiee
Jun 12, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dezhong ZhouWenxin Wang
Feb 9, 2017·Journal of Biomedical Materials Research. Part a·David R WilsonJordan J Green
Mar 31, 2017·Intractable & Rare Diseases Research·Ellie Rashidghamat, John A McGrath

❮ Previous
Next ❯

Citations

Sep 3, 2020·Trends in Biotechnology·Qurrat Ul AinSarah Hedtrich
Jun 5, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Yana V TarakanchikovaAlexander S Timin
Jun 11, 2021·Dermatology and Therapy·Tobias WelponerMartin Laimer
Jul 23, 2021·Advanced Drug Delivery Reviews·Ming ZengWenxin Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.